A Study of Oral Contraception Under Simulated OTC Conditions
Stopped Terminated prematurely due to issues with one of the data collection systems, no impact on subject safety
Conditions
Interventions
- DRUG: Norgestrel 0.075 mg tablets
Sponsor
HRA Pharma